Range Low Price High Price Comment
30 days $2.05 $2.65 Wednesday, 27th Mar 2024 CHRS stock ended at $2.42. This is 5.22% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 7.02% from a day low at $2.28 to a day high of $2.44.
90 days $1.93 $3.70
52 weeks $1.44 $8.65

Historical Coherus BioSciences prices

Date Open High Low Close Volume
2021-07-21 $13.12 $13.55 $12.88 $13.12 587 842
2021-07-20 $13.07 $13.28 $12.95 $13.13 496 852
2021-07-19 $12.90 $13.23 $12.68 $12.98 600 570
2021-07-16 $13.30 $13.30 $12.96 $13.01 403 833
2021-07-15 $13.03 $13.32 $12.90 $13.13 613 910
2021-07-14 $13.31 $13.37 $13.01 $13.14 644 642
2021-07-13 $13.24 $13.50 $13.02 $13.31 592 525
2021-07-12 $13.46 $13.57 $13.21 $13.33 399 509
2021-07-09 $13.50 $13.60 $13.15 $13.53 367 220
2021-07-08 $13.18 $13.76 $13.18 $13.42 661 601
2021-07-07 $13.52 $13.59 $13.32 $13.40 452 258
2021-07-06 $13.73 $13.94 $13.60 $13.63 475 331
2021-07-02 $14.22 $14.22 $13.72 $13.73 388 700
2021-07-01 $13.77 $14.26 $13.70 $14.25 385 947
2021-06-30 $14.00 $14.05 $13.79 $13.83 450 374
2021-06-29 $14.51 $14.65 $14.02 $14.04 599 651
2021-06-28 $15.50 $15.50 $14.53 $14.54 606 859
2021-06-25 $15.00 $15.49 $15.00 $15.41 964 261
2021-06-24 $14.62 $15.22 $14.60 $15.21 570 538
2021-06-23 $15.09 $15.22 $14.48 $14.64 786 414
2021-06-22 $14.80 $15.07 $14.66 $15.07 863 849
2021-06-21 $14.24 $14.84 $14.02 $14.76 1 191 947
2021-06-18 $14.48 $14.48 $14.06 $14.15 1 236 786
2021-06-17 $14.15 $14.50 $14.13 $14.38 614 985
2021-06-16 $14.06 $14.39 $14.01 $14.35 890 541
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT